Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F11%3A00009451" target="_blank" >RIV/00023736:_____/11:00009451 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1186/1750-9378-6-9" target="_blank" >http://dx.doi.org/10.1186/1750-9378-6-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/1750-9378-6-9" target="_blank" >10.1186/1750-9378-6-9</a>
Alternative languages
Result language
angličtina
Original language name
Human papillomavirus serologic follow-up response and relationship to survival in head and neck cancer: a case-comparison study
Original language description
The purpose of this study was to determine whether antibody levels to the HPV-16 oncoproteins E6 and E7 measured in sera collected at baseline (BL) prior to treatment and at two post-treatment follow-up (FU) visits were associated with HNC risk factors or prognosis. These findings are the first to follow post-treatment OD levels of HPV-16 E6 and E7 in HNC and suggest that these HPV antibodies may be potential prognostic markers of survival in HNC patients.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Infectious Agents and Cancer
ISSN
1750-9378
e-ISSN
—
Volume of the periodical
6
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
9
Pages from-to
1-9
UT code for WoS article
—
EID of the result in the Scopus database
—